entity

ALS risk

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ALS risk: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections

0Hypotheses

2Analyses

0Outgoing

3Incoming

0Experiments

2Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (3)

Source	Relation	Type	Str
Ataxin-2 expansions	risk_factor_for	gene	0.70
Ataxin-2 polyglutamine expansions	risk_factor_for	gene	0.70
TYROBP	associated_with	protein	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

What are the molecular signatures that distinguish protective vs. harmful microg

neurodegeneration | 2026-04-12 | 0 hypotheses

How do disease-associated mutations in G3BP1 or its binding partners alter stres

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.700

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The study establishes G3BP1's role as a tunable switch for stress granule assemb

closed · Rounds: 4 · Score: 0.69 · 2026-04-22

The debate transcript shows incomplete information exchange, suggesting this fun

closed · Rounds: 4 · Score: 0.49 · 2026-04-18

Related Research

Hypotheses and analyses mentioning ALS risk in their description or question text

No additional research found